Clinical Trial

Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie

Study acronym: PDR-CARE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2026 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goals of this study is to establish the prevalence of severe forms of FCR in the oncology hospital setting, which will require a specific psychotherapeutic response. Two cancer sites are targeted: breast and pulmonary cancers. Secondary objectives include: 1) Determining threshold scores for the FCRI's 9-item severity scale for each type of cancer; 3) To identify a simple item from the FCRI for early detection of FCR in everyday clinical practice, especially using a digital format.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-12.
Trial Details
NCT Number NCT07357311
Lead Sponsor Institut Curie
Conditions Lung Cancer, Breast Cancer
Enrollment 200 participants
Start Date 2025-09-08
Primary Completion 2026-01-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-23